We are live on ! Find out more
OASM

Oasmia Pharmaceutical AB
OASM

Delisted

OASM was delisted on the 21st of August, 2019.

8 hedge funds and large institutions have $187K invested in Oasmia Pharmaceutical AB in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more funds holding

Funds holding: 58 (+3)

42% less capital invested

Capital invested by funds: $323K → $187K (-$136K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CLOS
1
Compagnie Lombard Odier SCmA
Switzerland
$76K
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$50K +$60.2K +21,977 New
Jane Street
3
Jane Street
New York
$27K -$123K -44,720 -79%
OMC
4
Old Mission Capital
Illinois
$24K +$28.6K +10,431 New
UBS Group
5
UBS Group
Switzerland
$8K -$1.14K -417 -10%
Deutsche Bank
6
Deutsche Bank
Germany
$2K -$23.3K -8,500 -87%
Morgan Stanley
7
Morgan Stanley
New York
-$3 -1 -8%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
+$480 +175 New